NWCL NEWCLEO PLC
FollowOrdinary Shares, par value $0.02288 per share. (common), issuer CIK 2131813
Filings received so far for Q3 2026: 13 13F filers report a position in NWCL shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Fin Posillipo S.p.A. (group Marco Nuzzo)
20,301,194 shares, 7.2% in a 13G as of 2026-09-21,0000950103-26-017302
Accepted , ingested - Elysia Capital I SCSp (group Elysia Capital I SCSp)
20,123,335 shares, 7.1% in a 13G as of 2026-09-21,0000950103-26-015613
Accepted , ingested - Simon Fiduciaria S.p.A.
15,079,795 shares, 5.4% in a 13G as of 2026-09-21,0000950103-26-015614
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
Houmeau Matthieu reported holdings of NWCL shares in a Form 3 filed 2026-11-19. 0000950103-26-017857
Accepted , ingestedFin Posillipo S.p.A. and 1 other reporting person reported 20,301,194 NWCL shares, 7.2% of the class, as of 2026-09-21, in a 13G filed 2026-11-12. 0000950103-26-017302
Accepted , ingestedSimon Fiduciaria S.p.A. reported 15,079,795 NWCL shares, 5.4% of the class, as of 2026-09-21, in a 13G filed 2026-10-15. 0000950103-26-015614
Accepted , ingestedElysia Capital I SCSp and 1 other reporting person reported 20,123,335 NWCL shares, 7.1% of the class, as of 2026-09-21, in a 13G filed 2026-10-15. 0000950103-26-015613
Accepted , ingested